RMD earnings call for the period ending December 31, 2019.
News & Analysis: ResMed
This medical device maker reported solid top line growth while edging out Wall Street's expectations.
Five whistleblower lawsuits allege the company was illegally paying healthcare providers to use its devices.
Investors can earn both a good dividend and some capital appreciation with these stocks.
Markets finished the week on a positive note.
Shares hit an all-time high after the medical device maker posts strong quarterly results.
The healthcare company easily topped Wall Street revenue and earnings estimates.
RMD earnings call for the period ending September 30, 2019.
The CPAP pioneer has a phenomenal track record of success, but should investors jump on board today?
Revenue and gross margin continue to be strong, but acquisition costs continue to put pressure on the bottom line.